Bradley R Robinson

US Patent:

7048720, May 23, 2006

Filed:

Nov 22, 2005

Appl. No.:

11/284504

Inventors:

Nestor Rodriguez San Juan - Eaton PA, US
Michael Wallace Howlett - Salt Lake City UT, US
Bradley Carling Robinson - North Salt Lake UT, US
Gale H. Thorne - Bountiful UT, US

Assignee:

Infusive Technologies, LLC - Bountiful UT

International Classification:

A61M 5/00
A61M 5/315

US Classification:

604191, 604231

Abstract:

A valve assembly is disclosed which partitions a conventional syringe into proximal and distal chambers to provide a multi-chamber, sequentially dispensing syringe apparatus. Incorporated in the valve assembly is a valved stopper having a valve (e. g. a slit valve) and a separator which filters out gas from liquid being dispensed through the valve assembly. A syringe plunger communicates through fluid in the proximal chamber to force displacement of the valve assembly. The valve is actuated by differential pressure of a force greater than the valve assembly displacement force. The valve assembly may be made from two parts: (1) a valved stopper (may be molded from basic syringe plunger material); (2) a separator (may be injection molded from syringe barrel material). Key features of such a multi-chamber syringe apparatus are (1) fluids in the chambers are kept disparate; (2) the valve assembly may be used in conventional syringes; (3) gas in a closed chamber is filtered from delivered liquid; (4) bi-stable operation of a valve assembly valve permits reflux free operation; (5) a clinch in the separator holds the valve securely closed until the valve is opened by a predetermined action, such action being tactilely sensible. A tubing set is disclosed which may be added to provide a third disparate chamber.

US Patent:

20080319400, Dec 25, 2008

Filed:

Mar 19, 2008

Appl. No.:

12/051717

Inventors:

Gale H. Thorne - Bountiful UT, US
Bradley Carling Robinson - North Salt Lake UT, US
Michael Wallace Howlett - Salt Lake City UT, US
James Victor Mercer - West Jordan UT, US
Nestor Rodriguez San Juan - Hamburg NJ, US

International Classification:

A61M 5/19

US Classification:

604191

Abstract:

A syringe is partitioned into at least proximal and distal chambers to provide a multi-chamber, sequentially dispensing syringe apparatus. The syringe includes a gas separator that prevents gas from exiting a chamber with delivered fluid.

US Patent:

20210069257, Mar 11, 2021

Filed:

Aug 15, 2018

Appl. No.:

16/639353

Inventors:

- Sait Lake City UT, US
Bradley C. ROBINSON - Salt Lake City UT, US

International Classification:

A61K 35/51
A61K 35/28
A61K 35/50
A61P 17/02
A61K 47/36
A61K 47/10
A61K 9/06

Abstract:

Disclosed herein are compositions, formulations, methods, and kits for treating a skin condition.

US Patent:

20200250690, Aug 6, 2020

Filed:

Jan 31, 2019

Appl. No.:

16/263083

Inventors:

- San Francisco CA, US
Samuel Parsons - Washington D.C. DC, US
Bradley P. Robinson - San Francisco CA, US
Charles Heredia - Daly City CA, US
Shacarah Gagnon-Kvale - Duluth MN, US

International Classification:

G06Q 30/02

Abstract:

A server may be utilized as a content management server for receiving, validating, and formatting an object for use by a second server. The server may receive a selection of a digital communication message type, receive a set of content data corresponding to the selected message type and an indication of one or more target segments. Based on the selected communication message type, the server may validate the data. If the data is validated, then the server generates a communication message content payload object. The communication message content payload object is formatted based on the requirements of the second server, such that the second server may efficiently process the objects for distribution of communication messages using the data of the object. The second server may generate and transmit previews of messages to the first server, for review and approval by an authorized user.

US Patent:

20190142843, May 16, 2019

Filed:

Jan 11, 2019

Appl. No.:

16/245564

Inventors:

- Salt Lake City UT, US
Bradley C. ROBINSON - Salt Lake City UT, US

International Classification:

A61K 31/567
A61K 31/585
A61K 31/138
A61K 45/06
A61K 31/536
A61K 31/192
A61K 31/12
A61K 36/00
A61K 31/415
A61K 31/57
A61K 31/352
A61K 38/38
A61K 36/185
A61K 31/5415

Abstract:

The present invention is a compound comprising an anti-inflammatory drug component consisting preferably of at least one of an NSAID portion and a cannabis portion and at least one of a progestin component and a progesterone component. The compound may take for instance the form of a pill or pellet (for oral internal use or for subdermal implantation), an injectable solution, or a suppository. The compound is intended for use in treating subjects having or being at increased risk—especially genetically determined risk—of developing endometriosis. The compound may also be used for treating other disorders or as a contraceptive.

US Patent:

20170112881, Apr 27, 2017

Filed:

Jan 5, 2017

Appl. No.:

15/399532

Inventors:

Bradley C. Robinson - North Salt Lake UT, US

Assignee:

Predictive Therapeutics, LLC - North Salt Lake UT

International Classification:

A61K 35/51
A61K 9/08
A61K 9/00

Abstract:

The present invention is a method of treating or preventing endometriosis by means of administering stem cells to a patient. The stem cells are preferably drawn from umbilical cord tissue and/or umbilical cord blood and are preferably combined with a liquid carrier to form a stem cell solution. In the case of a female patent asymptomatic of endometriosis but at increased risk of developing endometriosis due to at least one endometriosis associated genetic marker being known to exist in the patient, the stem cell solution is preferably injected in the general abdominal/rectal/vaginal area of the patient. In the case of a female patent known to have endometriosis, the stem cell solution may be injected directly into endometrial tissue, and more especially into an endometrial lesion of the patient. The stem cell solution may also be used for treating other disorders such as infertility.

US Patent:

20160022696, Jan 28, 2016

Filed:

Oct 5, 2015

Appl. No.:

14/875656

Inventors:

Bradley C. Robinson - North Salt Lake UT, US

Assignee:

Predictive Therapeutics, LLC - North Salt Lake UT

International Classification:

A61K 31/567
A61K 31/192
A61K 31/352
A61K 38/38

Abstract:

The present invention is a compound comprising an anti-inflammatory drug component consisting preferably of at least one of an NSAID portion and a cannabis portion and at least one of a progestin component and a progesterone component. The compound may take for instance the form of a pill or pellet (for oral internal use or for subdermal implantation), an injectable solution, or a suppository. The compound is intended for use in treating subjects having or being at increased risk—especially genetically determined risk—of developing endometriosis. The compound may also be used for treating other disorders or as a contraceptive.

US Patent:

20140348957, Nov 27, 2014

Filed:

May 19, 2014

Appl. No.:

14/281127

Inventors:

Bradley C. Robinson - North Salt Lake UT, US

International Classification:

A61K 31/567
A61K 31/536
A61K 31/415
A61K 31/12
A61K 31/192
A61K 31/5415

US Classification:

424725, 514171, 514164, 514161

Abstract:

The present invention is a compound comprising an NSAID portion and at least one of a progestin portion and a progesterone portion. The compound may take for instance the form of a pill or pellet (for oral internal use or for subdermal implantation), an injectable solution, or a suppository. The compound is intended for use in treating subjects having or being at increased risk—especially genetically determined risk—of developing endometriosis. The compound may also be used for treating other disorders or as a contraceptive.